Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles.
[Therapeutic options for autoimmune encephalomyelitis].
Abnormalities of cerebral blood flow in multiple sclerosis: A pseudocontinuous arterial spin labeling MRI study.
Acute disseminated encephalomyelitis.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.
Genetic burden in multiple sclerosis families.
Epidemiology and clinical record of multiple sclerosis in selected countries - a systematic review.
TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3(+) Treg cells.
Identification of Bax-Interacting Proteins in Normal Oligodendrocyte Progenitors during Glutamate Excitotoxicity and Perinatal Hypoxia-Ischemia.
Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.
Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
Calcium intervention ameliorates experimental model of multiple sclerosis.
GM-CSF-Neuroantigen Fusion Proteins Reverse Experimental Autoimmune Encephalomyelitis and Mediate Tolerogenic Activity in Adjuvant-Primed Environments: Association with Inflammation-Dependent, Inhibitory Antigen Presentation.
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Transplanting of Mesenchymal Stem Cells May Affect Proliferation and Function of CD4+T Cells in Experimental Autoimmune Encephalomyelitis.
Estimating Brain Lesion Volume Change in Multiple Sclerosis by Subtraction of Magnetic Resonance Images.
Central Neuropathic Pain Syndromes.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders.
Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
Exploring the Role of Nerve Growth Factorin Multiple Sclerosis: Implications in Myelin Repair.
Pages
« first
‹ previous
…
440
441
442
443
444
445
446
447
448
…
next ›
last »